EP 1928468 A2 20080611 - ESTRIOL THERAPY FOR AUTOIMMUNE AND NEURODEGENERATIVE DISEASES AND DISORDERS
Title (en)
ESTRIOL THERAPY FOR AUTOIMMUNE AND NEURODEGENERATIVE DISEASES AND DISORDERS
Title (de)
ÖSTRIOL-THERAPIE GEGEN AUTOIMMUNKRANKHEITEN UND NEURODEGENERATIVE ERKRANKUNGEN UND STÖRUNGEN
Title (fr)
THERAPIE PAR ESTRIOL POUR MALADIES ET TROUBLES NEURODEGENERATIFS ET AUTOIMMUNS
Publication
Application
Priority
- US 2006037259 W 20060926
- US 72097105 P 20050926
- US 83352706 P 20060726
Abstract (en)
[origin: WO2007038435A2] The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, including post-partum auto immune diseases) and more particularly. Most preferably the invention uses estrogens, estranges, estriol or estrogen receptor active agents to prevent or ameliorate clinical symptoms of these ThI -mediated (cell-mediated) autoimmune diseases known to either have an initial onset following the birth of a child or which are exacerbated in patients in the post¬ partum period.
IPC 8 full level
G01N 33/00 (2006.01); A61K 31/565 (2006.01); A61K 31/566 (2006.01); A61K 31/568 (2006.01); A61K 45/06 (2006.01)
CPC (source: EP)
A61K 31/56 (2013.01); A61P 5/16 (2017.12); A61P 17/06 (2017.12); A61P 25/00 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 37/06 (2017.12); A61P 43/00 (2017.12)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2007038435 A2 20070405; WO 2007038435 A3 20070628; AU 2006294826 A1 20070405; CA 2623905 A1 20070405; EP 1928468 A2 20080611; EP 1928468 A4 20101208; JP 2009510070 A 20090312
DOCDB simple family (application)
US 2006037259 W 20060926; AU 2006294826 A 20060926; CA 2623905 A 20060926; EP 06815340 A 20060926; JP 2008533482 A 20060926